We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editor's Correspondence |

Apparent Warfarin Potency Inconsistencies Compromise Effectiveness

Bruce M. Rothschild, MD
Arch Intern Med. 2003;163(10):1243. doi:10.1001/archinte.163.10.1243-a.
Text Size: A A A
Published online


An alternative message can perhaps be derived from the article by Meyer et al.1 The article documents that INR was outside therapeutic range in 59% of patients receiving warfarin. The inference is that appropriate levels of anticoagulation control were not achieved in almost half. Is this acceptable? Is there a problem with the paradigm or is medication potency undependable?

Such a problem was uncovered several years ago when inconsistency in warfarin sodium (Coumadin; DuPont Pharma, Wilmington, Del) potency was discovered.2 At that time, the problem was attributed to excess heat exposure during postal transport of the mail order prescription. Subsequently, we have had reason to suspect a larger problem. Wide weekly variation in individual patient dosage response made anticoagulation control challenging.3 A search for confounding factors was unsuccessful. Only the Dupont trade name product had been provided. There had been no alteration in concomitant medication or health product ingestion or dietary habits (eg, variable ingestion of vitamin K–containing foods).



Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles

Users' Guides to the Medical Literature
Assessing the Strength of Recommendations: The GRADE Approach

Users' Guides to the Medical Literature
Are the Results Valid?